脑转移
乳腺癌
医学
肿瘤科
癌症研究
细胞周期蛋白依赖激酶4
内科学
激酶
转移
癌症
生物
细胞周期蛋白依赖激酶2
遗传学
细胞周期
作者
Sonya Chew,Emanuela Ferraro,Anton Safonov,Yuan Chen,Daniel J. Kelly,Pedram Razavi,Mark E. Robson,Andrew D. Seidman
标识
DOI:10.1016/j.ejca.2024.114175
摘要
Cyclin dependent kinase 4/6 inhibitors (CDK4/6i) are recommended 1st line treatments in HR+HER2- metastatic breast cancer. However, the impact of prior CDK4/6i on the natural history of brain metastases (BM) is not well described.
科研通智能强力驱动
Strongly Powered by AbleSci AI